top of page
Bioprocessing

Andelyn reaches commercial manufacturing milestone following FDA approval of Fayuvi
Andelyn Biosciences has reached a commercial manufacturing milestone following the U.S. Food and Drug Administration’s (FDA) approval of Ultragenyx Pharmaceutical’s Fayuvi™ gene therapy for Sanfilippo syndrome type A.
bottom of page






